Tivan validates premium fluorspar for Asian markets

Grafa
Tivan validates premium fluorspar for Asian markets
Tivan validates premium fluorspar for Asian markets
Liezl Gambe
Written by Liezl Gambe
Share

Tivan (ASX:TVN) announced an advancement in the commercialisation of its Speewah Fluorite Project in Western Australia, following the validation of its product by major Asian markets.

Independent technical assessments conducted by three potential end-users in Asia have confirmed that the project's acid-grade fluorspar meets the rigorous specifications required for high-purity hydrofluoric acid production.

This validation is a pivotal step for the company, as the low levels of arsenic, phosphorus, and sulphides found in the Speewah samples are essential for manufacturing the ultra-pure HF used in semiconductor fabrication and other advanced technological sectors.

The feedback follows a series of high-level technical meetings held in March between Tivan, its joint venture partner Sumitomo Corporation, and the interested Asian parties.

To capitalise on this momentum, Tivan has initiated a "mini-pilot" programme at ALS Metallurgy in Perth.

The phase focuses on refining process engineering and generating a larger batch of product samples to support ongoing marketing efforts led by Sumitomo.

The partnership remains robust, underpinned by a previously agreed term sheet that could see Sumitomo Corporation take up to 100% of the project’s lifetime output, with 80% secured on a "take or pay" basis.

As the joint venture—which also includes the Japan Organisation for Metals and Energy Security—progresses, these latest results solidify Speewah’s potential as a premier global supplier of critical industrial minerals.

At the time of reporting, Tivan's share price was $0.35.

Frequently asked questions

Connect with us

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.